ATAD2 and hepatocellular carcinoma: Moreover, ERO1L and G3BP2 significantly inhibited HCC cell migration, suggesting that ANCCA/PRO2000 could enhance cell migratory capacity at least partially by negatively regulating ERO1L and G3BP2 expression.